Adalimumab procurement framework extended
NHS England has extended the procurement framework for adalimumab by four months to 31 March 2020. (Source: NHS Networks)
Source: NHS Networks - September 8, 2019 Category: UK Health Source Type: news

NHS saves £300MILLION in a year by telling doctors to stop giving out expensive branded medications
Hospitals spent £290million on adalimumab - a drug primarily used to treat arthritis but also given to patients with Crohn's disease - in 2018/19. (Source: the Mail online | Health)
Source: the Mail online | Health - August 31, 2019 Category: Consumer Health News Source Type: news

These are the top 25 costliest prescription drugs for Oregon insurers
Humira is the best-selling medicine in the world and a gold mine for drug maker AbbVie, bringing in $4.87 billion in revenue globally in the second quarter. The drug, which treats rheumatoid arthritis and Crohn's disease, costs upwards of $60,000 a year. So it may come as no surprise that Humira is on the list of the 25 most costly drugs for Oregon health insurers in 2018. The combined list is based on the rankings submitted by nine insurance comp anies and takes into account total annual spending,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 20, 2019 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

AbbVie ’s Humira follow-up gets FDA nod
A potential new blockbuster from AbbVie has gotten the go-ahead from the FDA. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 19, 2019 Category: Pharmaceuticals Source Type: news

AbbVie prices new rheumatoid arthritis drug at $59,000 a year
AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on Friday, a big boost for the drugmaker struggling with rising competition for Humira, its blockbuster therapy for the same condition. (Source: Reuters: Health)
Source: Reuters: Health - August 16, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Hadlima (Adalimumab-bwwd Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 1, 2019 Category: Drugs & Pharmacology Source Type: news

Adalimumab in tight-control approach cost effective in Crohn's
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 31, 2019 Category: Drugs & Pharmacology Source Type: news

Humira biosim wins FDA approval
The clock is ticking on how much longer the world ’s best-selling drug will be free from biosimilar competition in the U.S. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 24, 2019 Category: Pharmaceuticals Source Type: news

Merck's Biosimilar to AbbVie's Humira Wins FDA Approval Merck's Biosimilar to AbbVie's Humira Wins FDA Approval
The U.S. Food and Drug Administration approved Merck& Co Inc ' s biosimilar to AbbVie Inc ' s blockbuster rheumatoid arthritis treatment Humira (adalimumab), the health agency said on Tuesday.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 24, 2019 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Samsung Bioepis Humira biosimilar wins FDA approval
(This story corrects to show that Hadlima belongs to Samsung Bioepis not Merck& Co Inc, which is commercializing the drug in the United States) (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Approves Hadlima (adalimumab-bwwd), a Biosimilar to Humira
INCHEON, Korea– July 24, 2019– Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Hadlima (adalimumab-bwwd), a biosimilar referencing Humira (adalimumab)i, for the treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 23, 2019 Category: Drugs & Pharmacology Source Type: news

Merck's biosimilar to AbbVie's Humira wins FDA approval
The U.S. Food and Drug Administration approved Merck& Co Inc's biosimilar to AbbVie Inc's blockbuster rheumatoid arthritis treatment Humira, the health agency said on Tuesday. (Source: Reuters: Health)
Source: Reuters: Health - July 23, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

There Is No Single, Best Policy for Drug Prices
Most Americans would like the government to act, but a one-size-fits-all approach is unlikely to be the answer. (Source: NYT)
Source: NYT - July 15, 2019 Category: American Health Authors: Austin Frakt Tags: Drugs (Pharmaceuticals) Prices (Fares, Fees and Rates) Inventions and Patents Generic Brands and Products Food and Drug Administration Humira (Drug) Source Type: news

adalimumab (Humira)
Title: adalimumab (Humira)Category: MedicationsCreated: 1/22/2003 12:00:00 AMLast Editorial Review: 7/1/2019 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - July 1, 2019 Category: Rheumatology Source Type: news

Proactive Drug Monitoring Improves Outcomes in Kids With Crohn ’ s Proactive Drug Monitoring Improves Outcomes in Kids With Crohn ’ s
Proactive therapeutic-drug monitoring (TDM) in children with Crohn ' s disease on adalimumab reduces clinical exacerbations compared to reactive TDM, a randomized controlled trial shows.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 26, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news